EUVIMEDEUVIMED entdecken
Open Access

Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024

Robert J Calzaretta, Stephen Fink, Kabir Kothari, Thomas C Tsai

JAMA Surgery · 01.07.2026 · 161 (7) · 746

DOI: 10.1001/jamasurg.2026.1343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.07.2026. Verfasst von Robert J Calzaretta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Analysis Group, Boston, Massachusetts and San Francisco, California. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines trends in metabolic bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists.

Autor:innen und Institutionen

  • Analysis Group, Boston, Massachusetts and San Francisco, California.
  • Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • American College of Surgeons, Washington, DC.

Zitieren

APA

Calzaretta, R. J., Fink, S., Kothari, K., & Tsai, T. C. (2026). Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024. JAMA Surgery, 161(7), 746. https://doi.org/10.1001/jamasurg.2026.1343

Vancouver

Calzaretta RJ, Fink S, Kothari K, Tsai TC. Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024. JAMA Surgery. 2026;161(7):746. doi:10.1001/jamasurg.2026.1343

BibTeX
@article{Calzaretta2026,
  author = {Calzaretta, Robert J and Fink, Stephen and Kothari, Kabir and Tsai, Thomas C},
  title = {Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024},
  journal = {JAMA Surgery},
  year = {2026},
  volume = {161},
  number = {7},
  pages = {746},
  doi = {10.1001/jamasurg.2026.1343}
}
Kostenlos starten →